Publication | Closed Access

A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

OncologyCancer CachexiaRtog 0122Chemoprevention StrategyPharmacologyClinical TrialsPharmacotherapyAnti-cancer AgentCancer TreatmentArginine MixtureMedicineCancer ResearchCancer Metabolism